RIGL vs SVRA: stock comparison and AI forecast
Rigel Pharmaceuticals Inc (RIGL) and Savara Inc (SVRA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
RIGL Rigel Pharmaceuticals Inc
- Price
- $50.53 +71.1% · 6M
- Market Cap
- $913M
- P/E Ratio
- 2.9x
- Size
- small-cap
- AI Forecast
SVRA Savara Inc
- Market Cap
- $990M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- RIGL and SVRA have similar market capitalizations ($913M and $990M).
- SVRA carries 0.34 times debt per unit of equity, against 0.22 times for RIGL.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | RIGL | SVRA |
|---|---|---|
| Market Cap | $913M | $990M |
| P/E Ratio | 2.86x | – |
| P/B Ratio | 2.15x | 6.89x |
| EPS | $17.08 | $-0.55 |
| Book Value/Share | $22.77 | $0.70 |
| Revenue/Share | $17.67 | – |
| FCF/Share | – | $-0.54 |
Profitability & Margins
| Metric | RIGL | SVRA |
|---|---|---|
| ROE | 75.7% | -97.6% |
| ROA | 61.8% | -72.9% |
| ROIC | 20.5% | -82.3% |
| Gross Margin | 92.8% | – |
| Operating Margin | 26.4% | – |
| Net Margin | 97.5% | – |
| EBT Margin | 25.9% | – |
| Tax Rate | -276.2% | – |
Financial Health
| Metric | RIGL | SVRA |
|---|---|---|
| Current Ratio | 1.94x | 10.13x |
| Quick Ratio | 1.79x | – |
| D/E Ratio | 0.22x | 0.34x |
| Financial Leverage | 1.22x | 1.34x |
| Interest Coverage | 29.5x | -65.1x |
| Working Capital | $90M | $161M |
Cash Flow
| Metric | RIGL | SVRA |
|---|---|---|
| Operating Cash Flow | $79M | -$110M |
| Free Cash Flow | – | -$111M |
| Capital Spending | – | -$280K |
| OCF Growth YoY | 20.6% | – |
Operational Efficiency
| Metric | RIGL | SVRA |
|---|---|---|
| Asset Turnover | 0.63x | – |
| Receivables Turnover | 5.9x | – |
| Inventory Turnover | 1.7x | – |
| Days Sales Outstanding | 62 days | – |
| Days Inventory | 220 days | – |
| Payables Period | 61 days | – |
| Cash Conversion Cycle | 221 days | – |
Income Statement
| Metric | RIGL | SVRA |
|---|---|---|
| Total Revenue | $330M | – |
| Operating Income | $87M | -$144M |
| Net Income | $322M | -$140M |
| R&D Expense | $44M | $87M |
| SG&A Expense | $122M | – |
| Cost of Goods Sold | $24M | – |
Dividend & Shareholder Information
| Metric | RIGL | SVRA |
|---|---|---|
| Shares Outstanding | 19M | 205M |
| Net Income Growth | 317.2% | – |
| EPS Growth | 294.5% | – |
RIGL vs SVRA: stock comparison and AI forecast
Which is bigger, RIGL or SVRA?
RIGL and SVRA have similar market capitalizations ($913M and $990M).
Which one does Intratio's AI model rank higher, RIGL or SVRA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.